Atypical and incomplete Kawasaki disease

Area of Science:

• Pediatrics
• Rheumatology
• Immunology

Background:

• Kawasaki disease (KD) is the most frequent childhood systemic vasculitis and a leading cause of acquired heart disease in Western countries.
• Diagnosis primarily relies on clinical manifestations, as laboratory tests lack specificity for KD.
• Atypical or incomplete presentations pose diagnostic challenges, often requiring expert clinical judgment.

Purpose of the Study:

• To review the diagnostic challenges and evolving treatment approaches for Kawasaki disease.
• To highlight the importance of clinical expertise in managing KD, particularly in infants and complex cases.
• To underscore the need for a definitive diagnostic standard for Kawasaki disease.

Main Methods:

• Review of clinical findings and diagnostic criteria for Kawasaki disease.
• Discussion of laboratory test utility and limitations in KD diagnosis.
• Analysis of treatment and follow-up strategies based on diagnostic probability and clinical presentation.

Main Results:

• Kawasaki disease diagnosis remains largely clinical, with no specific laboratory biomarkers.
• Atypical and incomplete KD cases present significant diagnostic difficulties.
• Management decisions for KD are individualized, considering diagnostic certainty, illness duration, and therapeutic goals.

Conclusions:

• Expert clinical assessment is crucial for diagnosing Kawasaki disease, especially in atypical presentations.
• Current diagnostic approaches for KD require refinement, with an ongoing need for a gold standard.
• Individualized treatment and follow-up are essential for managing Kawasaki disease effectively.